Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas

Journal of Clinical Investigation

Volumn 103, Issue 1, 1999, Pages 137-145

  Faubion, William A ^a   Guicciardi, M Eugenia ^a   Miyoshi, Hideyuki ^a   Bronk, Steven F ^a   Roberts, Patricia J ^a   Svingen, Phyllis A ^a   Kaufmann, Scott H ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; CASPASE; CATHEPSIN B; FAS ANTIGEN; GLYCOCHENODEOXYCHOLIC ACID; GREEN FLUORESCENT PROTEIN; LAMIN B; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER CELL; LIVER INJURY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032919402     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4765     Document Type: Article

References (42)

1. Schmucker, D.L., Ohta, M., Kanai, S., Sato, V., and Kitani, K. 1990. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology. 12:1216-1221.
2. Greim, H., et al. 1972. Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology. 63:837-845.
3. Greim, H., et al. 1972. Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology. 63:846-850.
4. Patel, T., Bronk, S.F., and Gores, G.J. 1994. Increases of intracellular magnesium promote glycochenodeoxycholate-induced apoptosis in rat hepatocytes. J. Clin. Invest. 94:2183-2192.
5. Kwo, P., Patel, T., Bronk, S.F., and Gores, G.J. 1995. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. Am. J. Physiol. (Lond.). 268:G613-G621.
6. Patel, T., Gores, G.J., and Kaufmann, S.H. 1996. The role of proteases during apoptosis. FASEB J. 10:587-597.
7. Fraser, A., and Evan, G. 1996. A license to kill Cell. 85:781-784.
8. Roberts, L.R., et al. 1997. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology. 12:1-10.
9. Jones, B.A., Roberts, P.J., Faubion, W.A., Kominami, E., and Gores, G.J. 1998. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am. J. Physiol. 275:G723-G730.
10. Faleiro, L., Kobayashi, R., Fearnhead, H., and Lazebnik, Y. 1997. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16:2271-2281.
11. Alnemri, E.S., et al. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
12. Humke, E.W., Ni, J., and Dixit, V.M. 1998. ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 273:15702-15707.
13. Salvesen, G., and Dixit, V.M. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
14. Ahmad, M., et al. 1997. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57:615-619.
15. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. 1996. Involvement of MACH, a novel MORT/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell. 85:803-815.
16. Muzio, M., et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(APO-1) death-inducing signaling complex. Cell. 85:817-827.
17. Chinnaiyan, A.M., et al. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 274:990-992.
18. Ng, F., et al. 1997. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139:327-338.
19. Scaffidi, C. et al. 1998 Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675-1687.
20. Klaunig, J., et al. 1981, Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 17:913-925.
21. Que, F.G., Gores, G.J., and LaRusso, N.F. 1997. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am. J. Physiol. 272:G106-G115.
22. Thornberry, N.A., et al. 1994. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy) methyl ketones. Biochemistry. 33:3934-3940.
23. Zhou, Q., et al. 1997. Target protease specificity of the viral serpin CrmA: analysis of five caspases. J. Biol. Chem. 272:7797-7800.
24. Morrison, J.F. 1982. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions. Trends Biochem. Sci. 7:102-105.
25. Adjei, P., Kaufmann, S.H., Leung, W., Mao, F., and Gores, G.J. 1996. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest. 98:2588-2595.
26. Salvesen, G., and Stennicke, H. 1997. Biochemical characteristics of caspases-3, -6,-7, and -8. J. Biol. Chem. 272:25719-25723.
27. Bertin, J. et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1172-1176.
28. Wajant, H., et al. 1998. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr. Biol. 8:113-116.
29. Martins, L.M., et al. 1997. Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 272:7421-7430.
30. Aragane, Y., et al. 1998. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140:171-182.
31. Rehemtulla, A., Hamilton, C., Chinnaiyan, A.M. and Dixit, V.M. 1997. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J. Biol. Chem. 272:25783-25786.
32. Kurosawa, H., Que, F.G., Roberts, L.R., Fesmier, P.J., and Gores, G.J. 1997. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am. J. Physiol. 272;G1587-G1593.
33. Talanian, R.V., et al. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677-9682.
34. Srinivasan, A., et al. 1998. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 273:4523-4529.
35. Nagata, S. 1994. Mutations in the Fas antigen gene in lpr mice. Semin. Immunol. 6:3-8.
36. Ogasawara, J., et al. 1993. Lethal effect of the anti-Fas antibody in mice. Nature. 364:806-809.
37. Schneider, P., et al. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213.
38. Varfolomeev, E.E., et al. 1998. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, FAS/APO1, and DR3 and is lethal prenatally. Immunity. 9:267-276.
39. Cohen, G. 1997. Caspases; the executioners of apoptosis. Biochem. J. 326:1-16.
40. Monney, L., et al. 1997. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251:295-303.
41. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
42. Heuman, D., and Bajaj, R. 1994. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology. 106:1333-1341.